Streetbeat News

Products Services

BMEA

Biomea Fusion's stock initially rose after announcing new clinical data from its ongoing Phase II study of BMF-219 in type 2 diabetes patients, but has since sold off.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2023 | 4:45 pm

TFX

Teleflex and Arrow International are recalling 262,016 Arrow Endurance Extended Dwell Peripheral Catheter Systems in the US due to the risk of catheter separation or leakage, as announced by the U.S. FDA.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 4:42 pm

AGIO

Agios Pharmaceuticals announced that the Phase 2 portion of the RISE UP study of mitapivat in sickle cell disease met its primary endpoint of hemoglobin response. The results support proceeding with the Phase 3 portion of the study. Agios plans to analyze the data further to select a dose for the Phase 3 study, which is expected to enroll 198 patients and report data in 2025.

Portfolio Pulse from Vandana Singh

June 26, 2023 | 4:23 pm

HSBC

HSBC Holdings has ventured into cryptocurrency services, allowing its clients to purchase and sell Bitcoin and Ethereum ETFs listed on the Stock Exchange of Hong Kong. The bank is also launching the Virtual Asset Investor Education Center to safeguard investors from potential risks associated with cryptocurrency.

Portfolio Pulse from Murtuza Merchant

June 26, 2023 | 4:07 pm

BIOL

Biolase has been pre-solicited by the Department of Defense for dental equipment and supplies manufacturing, specifically for the company's Waterlase Express Endodontic Laser. Biolase is the sole manufacturer and distributor of the Waterlase iPlus Laser in the USA.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2023 | 3:48 pm

PBR

TTE

TotalEnergies SE, Petronas, and Mitsui have partnered to develop a carbon storage hub in Malaysia. They will evaluate CO2 storage sites in the Malay Basin, including saline aquifers and depleted offshore fields.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 3:22 pm

HZNP

Horizon Therapeutics' TEPEZZA has been approved by the Brazilian Health Regulatory Agency (ANVISA) for the treatment of active thyroid eye disease (TED). This marks the first approval of TEPEZZA outside the United States, addressing a significant unmet need for those living with this progressive autoimmune disease.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 3:02 pm

MSFT

SNOW

Snowflake shares are trading higher after announcing an expanded partnership with Microsoft, bringing generative AI models and machine learning capabilities to the data cloud. The partnership will enable new product integrations across AI, low code/no code application development, and data governance.

Portfolio Pulse from Erica Kollmann

June 26, 2023 | 2:59 pm

MRNA

Moderna's stock rose after submitting an updated vaccine application to the FDA. UBS analyst Eliana Merle upgraded Moderna's rating from Neutral to Buy, citing underappreciated potential for mRNA vaccines in diseases beyond Covid. The price target was reduced from $221 to $191.

Portfolio Pulse from Priya Nigam

June 26, 2023 | 2:56 pm

BTCUSD

Cryptosat has partnered with Dfns Labs to develop a Space Wallet, designed to secure high-value transactions using a threshold signature scheme with a satellite as a co-signer. The wallet is compatible with the Bitcoin blockchain and aims to reduce the risk of physical access-based attacks.

Portfolio Pulse from Murtuza Merchant

June 26, 2023 | 2:30 pm